Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
12.05.25
/
50%
€1.63
Target price
12.05.26
€3.56
Performance (%)
42.06%
Price
01.08.25
€2.32
Summary
This prediction is currently active. With a performance of 42.06% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 12.05.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -12.777% | -12.777% |
| iShares Core DAX® | -3.352% | -0.947% |
| iShares Nasdaq 100 | -0.740% | 3.167% |
| iShares Nikkei 225® | -1.885% | -0.531% |
| iShares S&P 500 | -0.952% | 2.583% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
-22.61%
01.08.25
01.08.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25